Pharmacy Society of Wisconsin

Registered Principal Details

Business Or Interest:
Pharmacy, pharmacists, pharmacy technician, student pharmacists, schools of pharmacy, pharmaceuticals, healthcare

Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy residents, pharmacy businesses, medication usage, medication costs, prescription drug use, medication use and abuse, and the practice of pharmacy.

CEO Name:
Sarah Sorum

Contact
DMW
Danielle M Womack
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 8
Assembly Bill 8
Relating to: agreements for direct primary care.

Bill Text and History

For
Notification Date
2/10/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 43
Assembly Bill 43
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)

Bill Text and History

For
Notification Date
3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 68
Assembly Bill 68
Relating to: the prescription drug monitoring program. (FE)

Bill Text and History

For
Notification Date
3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 104
Assembly Bill 104
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.

Bill Text and History

Against
Notification Date
3/12/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 127
Assembly Bill 127
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)

Bill Text and History

Against
Notification Date
3/12/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 173
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
4/15/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 4
Senate Bill 4
Relating to: agreements for direct primary care.

Bill Text and History

For
Notification Date
2/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 42
Senate Bill 42
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)

Bill Text and History

For
Notification Date
2/13/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 68
Senate Bill 68
Relating to: the prescription drug monitoring program. (FE)

Bill Text and History

2025 Wisconsin Act 5

For
Notification Date
3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 137
Senate Bill 137
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)

Bill Text and History

Against
Notification Date
5/20/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 203
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
7/29/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Corrections: Departmentwide
Biennial budget bill treatment of matter relating to
Corrections: Departmentwide

Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Health Services: Medicaid Services
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services

Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Insurance: Departmentwide
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide

Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Safety and Professional Services: Departmentwide
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Departmentwide

Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Safety and Professional Services: Professional Regulation and Administrative Services
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Professional Regulation and Administrative Services

Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Administrative Rulemaking Proceedings

Compounding pharmaceuticals
Agency Name
Pharmacy Examining Board (Phar)
Subject
Compounding pharmaceuticals
Scope Statement
SS 007_23
Other
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Controlled substances requirements
Agency Name
Pharmacy Examining Board (Phar)
Subject
Controlled substances requirements
Scope Statement
SS 044_23
For
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Agency Name
Pharmacy Examining Board (Phar)
Subject
Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Scope Statement
SS 089_24
Undisclosed
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Pharmacy workplace conditions
Agency Name
Pharmacy Examining Board (Phar)
Subject
Pharmacy workplace conditions
Scope Statement
SS 002_25
Undisclosed
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Access to opioid reversal agents
Development, drafting or introduction of a proposal relating to
Access to opioid reversal agents

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/31/2025
First Communication Date
1/28/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.

Pharmacist prescribing of contraception
Development, drafting or introduction of a proposal relating to
Pharmacist prescribing of contraception

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Pharmacy practice
Development, drafting or introduction of a proposal relating to
Pharmacy practice

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

PBM reform
Development, drafting or introduction of a proposal relating to
PBM reform

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/23/2025
First Communication Date
1/14/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.

Total Lobbying Effort

  2025
January - June
Total
Total Lobbying Expenditures 2025
January - June
$72,510.36
Total $72,510.36
Total Hours Communicating 2025
January - June
132.25
Total 132.25
Total Hours Other 2025
January - June
356.00
Total 356.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
5%
2025
July - December
2026
January - June
2026
July - December
Total 5%
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
5%
2025
July - December
2026
January - June
2026
July - December
Total 5%
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
10%
2025
July - December
2026
January - June
2026
July - December
Total 10%
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
10%
2025
July - December
2026
January - June
2026
July - December
Total 10%
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
25%
2025
July - December
2026
January - June
2026
July - December
Total 25%

Budget Bill Subjects

2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
5%
2025
July - December
2026
January - June
2026
July - December
Total 5%

Administrative Rulemaking Proceedings

2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
5%
2025
July - December
2026
January - June
2026
July - December
Total 5%
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
10%
2025
July - December
2026
January - June
2026
July - December
Total 10%

Topics Not Yet Assigned A Bill Or Rule Number

2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
20%
2025
July - December
2026
January - June
2026
July - December
Total 20%

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
5%
2025
July - December
2026
January - June
2026
July - December
Total 5%

Filed Statements of Lobbying Activity and Expenditures